John M. Bedtelyon

Array ( [id] => 5046764 [patent_doc_number] => 20070265438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'siRNA targeting polo-like kinase-1 (PLK-1)' [patent_app_type] => utility [patent_app_number] => 11/818936 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34486 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265438.pdf [firstpage_image] =>[orig_patent_app_number] => 11818936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83677 [patent_doc_number] => 07741304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Casein kinase 2 antisense therapy' [patent_app_type] => utility [patent_app_number] => 11/763366 [patent_app_country] => US [patent_app_date] => 2007-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13709 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741304.pdf [firstpage_image] =>[orig_patent_app_number] => 11763366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879271 [patent_doc_number] => 20080152654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 11/761940 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20757 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152654.pdf [firstpage_image] =>[orig_patent_app_number] => 11761940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629386 [patent_doc_number] => 08008272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon' [patent_app_type] => utility [patent_app_number] => 12/516311 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8185 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008272.pdf [firstpage_image] =>[orig_patent_app_number] => 12516311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713283 [patent_doc_number] => 08399424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Method for controlling the amount of gene product, and agent for controlling the amount of gene product' [patent_app_type] => utility [patent_app_number] => 12/303908 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 11170 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232635 [patent_doc_number] => 08198078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Fucosyl transferase gene' [patent_app_type] => utility [patent_app_number] => 11/808097 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 23 [patent_no_of_words] => 11312 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198078.pdf [firstpage_image] =>[orig_patent_app_number] => 11808097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392312 [patent_doc_number] => 20090209625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'MODULATION OF CHREBP EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/301460 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28902 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209625.pdf [firstpage_image] =>[orig_patent_app_number] => 12301460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658157 [patent_doc_number] => 20080027019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/748422 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 46889 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027019.pdf [firstpage_image] =>[orig_patent_app_number] => 11748422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813832 [patent_doc_number] => 20080194463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Antibacterial antisense oligonucleotide and method' [patent_app_type] => utility [patent_app_number] => 11/803107 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 38552 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194463.pdf [firstpage_image] =>[orig_patent_app_number] => 11803107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114765 [patent_doc_number] => 08158598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Compositions and their uses directed to PTPR alpha' [patent_app_type] => utility [patent_app_number] => 12/299610 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 18116 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158598.pdf [firstpage_image] =>[orig_patent_app_number] => 12299610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368798 [patent_doc_number] => 20090306357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCCR' [patent_app_type] => utility [patent_app_number] => 12/299583 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137602 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306357.pdf [firstpage_image] =>[orig_patent_app_number] => 12299583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368621 [patent_doc_number] => 20090306180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING EXPRESSION APOB' [patent_app_type] => utility [patent_app_number] => 12/299764 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137040 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306180.pdf [firstpage_image] =>[orig_patent_app_number] => 12299764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368446 [patent_doc_number] => 20090306005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF PCSK9' [patent_app_type] => utility [patent_app_number] => 12/299572 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137516 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306005.pdf [firstpage_image] =>[orig_patent_app_number] => 12299572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368620 [patent_doc_number] => 20090306179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCGR' [patent_app_type] => utility [patent_app_number] => 12/299609 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137509 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306179.pdf [firstpage_image] =>[orig_patent_app_number] => 12299609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8103909 [patent_doc_number] => 08153604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'CNS-tumor treatment method and composition' [patent_app_type] => utility [patent_app_number] => 12/297301 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 23 [patent_no_of_words] => 7937 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153604.pdf [firstpage_image] =>[orig_patent_app_number] => 12297301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586262 [patent_doc_number] => 20090105464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'PHYSIOLOGICALLY ACTIVE POLYPEPTIDE AND DNA' [patent_app_type] => utility [patent_app_number] => 11/737521 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5807 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105464.pdf [firstpage_image] =>[orig_patent_app_number] => 11737521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085862 [patent_doc_number] => 20070275913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO HEPCIDIN' [patent_app_type] => utility [patent_app_number] => 11/734562 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16357 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275913.pdf [firstpage_image] =>[orig_patent_app_number] => 11734562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5102056 [patent_doc_number] => 20070185318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'siRNA targeting connexin 43' [patent_app_type] => utility [patent_app_number] => 11/731894 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 34713 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185318.pdf [firstpage_image] =>[orig_patent_app_number] => 11731894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485869 [patent_doc_number] => 20090275634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/296455 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9028 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275634.pdf [firstpage_image] =>[orig_patent_app_number] => 12296455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028922 [patent_doc_number] => 20070270369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'USE OF HEPATITIS B X-INTERACTING PROTEIN (HBXIP) IN MODULATION OF APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 11/691393 [patent_app_country] => US [patent_app_date] => 2007-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22828 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270369.pdf [firstpage_image] =>[orig_patent_app_number] => 11691393 [rel_patent_id] =>[rel_patent_doc_number] =>)